Quantbot Technologies LP Syros Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.69 - $1.21 $896 - $1,573	-1,300 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.26 - $4.66 $4,238 - $6,058	1,300 New	1,300 $4,000
Q3 2021 Nov 09, 2021	SELL	$4.08 - $5.66 $5,304 - $7,358	-1,300 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.01 - $7.48 $4,509 - $6,732	900 Added 225.0%	1,300 $7,000
Q1 2021 May 14, 2021	BUY	$7.19 - $14.95 $2,876 - $5,980	400 New	400 $2,000
Q4 2020 Feb 12, 2021	SELL	$6.66 - $14.66 $1,332 - $2,932	-200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.69 - $14.47 $1,738 - $2,894	200 New	200 $1,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.